McKean Heidi, Looker Sherry, Hartmann Lynn C, Hayman Suzanne R, Kaur Judith S, McWilliams Robert R, Peethambaram Prema P, Stahl Jean F, Jatoi Aminah
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Nutr Educ Behav. 2008 May-Jun;40(3):144-8. doi: 10.1016/j.jneb.2007.08.009.
This study assessed osteoporosis knowledge deficits among cancer patients and their spouses/partners.
Single-institution survey (modified version of the Osteoporosis Knowledge Assessment Tool).
The Mayo Clinic in Rochester, Minnesota.
Consecutive chemotherapy-treated cancer patients (n = 285) with their spouses/partners (n = 101).
The main outcome was the percentage of cancer patients who incorrectly conveyed that 1) cancer treatment strengthens bones (or did not know) and/or 2) male cancer patients are not at risk for osteoporosis (or did not know).
Test scores and 95% confidence intervals (CI) as well as the correlation between patient and spouse/partner scores, are reported.
39% of patients (95% CI, 32% - 48%) thought cancer treatment strengthened bones or did not know, and 39% (95% CI, 32% - 48%) either answered that osteoporosis almost never occurred in men or did not know. The mean correct score on the modified Osteoporosis Knowledge Assessment Tool was 6.7 (95% CI, 6.7, 7.9), and scores from patients correlated with companion scores (r = 0.42; P < .001).
Chemotherapy-treated cancer patients and their companions have knowledge deficits concerning osteoporosis. Educational initiatives to increase awareness may be of value.
本研究评估癌症患者及其配偶/伴侣对骨质疏松症的认知缺陷。
单机构调查（骨质疏松症知识评估工具的修改版）。
明尼苏达州罗切斯特市的梅奥诊所。
连续接受化疗的癌症患者（n = 285）及其配偶/伴侣（n = 101）。
主要观察指标是癌症患者中错误传达以下信息的百分比：1）癌症治疗可增强骨骼（或不知道）和/或2）男性癌症患者无骨质疏松症风险（或不知道）。
报告测试分数和95%置信区间（CI）以及患者与配偶/伴侣分数之间的相关性。
39%的患者（95%CI，32% - 48%）认为癌症治疗可增强骨骼或不知道，39%（95%CI，32% - 48%）要么回答男性几乎不会发生骨质疏松症，要么不知道。改良的骨质疏松症知识评估工具的平均正确分数为6.7（95%CI，6.7，7.9），患者分数与伴侣分数相关（r = 0.42；P <.001）。
接受化疗的癌症患者及其伴侣对骨质疏松症存在认知缺陷。提高认识的教育举措可能具有价值。
